Describing Patient With DME, Their Patient Journey and Disease Progression - Trial NCT05966753
Access comprehensive clinical trial information for NCT05966753 through Pure Global AI's free database. This phase not specified trial is sponsored by Boehringer Ingelheim and is currently Not yet recruiting. The study focuses on Diabetic Macular Edema. Target enrollment is 182000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Boehringer Ingelheim
Timeline & Enrollment
N/A
Jul 31, 2023
Sep 30, 2023
Primary Outcome
Change in visual acuity,Progression to DME in the fellow eye,Initial treatment of DME,Central retinal thickness (CRT)
Summary
This study aims to characterize patients with diabetic macular edema (DME), their
 progression, the treatment received and associate the functional and physiological outcomes
 related to the treatment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05966753
Non-Device Trial